Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113830105 | 11383010 | 5 | F | 2014 | 20160623 | 20150814 | 20160712 | PER | US-PFIZER INC-2015267662 | PFIZER | 60.00 | YR | M | Y | 88.00000 | KG | 20160712 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113830105 | 11383010 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY (ONE IN THE MORNING AND ONE BEFORE BED) | 300 | MG | L68170 | 21446 | 75 | MG | BID | ||||
113830105 | 11383010 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY | 300 | MG | 21446 | 50 | MG | BID | |||||
113830105 | 11383010 | 3 | SS | LYRICA | PREGABALIN | 1 | 75 MG, 3X/DAY | 300 | MG | M60987 | 21446 | 75 | MG | TID | |||||
113830105 | 11383010 | 4 | SS | LYRICA | PREGABALIN | 1 | 100 MG, 3X/DAY | 300 | MG | M60987 | 21446 | 100 | MG | TID | |||||
113830105 | 11383010 | 5 | C | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 20 IU, 1X/DAY, AT BEDTIME | 0 | 20 | IU | INJECTION | QD | ||||||
113830105 | 11383010 | 6 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG (ONE PILL), 2X/DAY | 0 | 25 | MG | BID | |||||||
113830105 | 11383010 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, ONE PILL AT BEDTIME | 0 | 40 | MG | QD | |||||||
113830105 | 11383010 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, ONE PILL AT BEDTIME | 0 | 500 | MG | QD | |||||||
113830105 | 11383010 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | ||||||||
113830105 | 11383010 | 10 | C | NOVOLIN R | INSULIN HUMAN | 1 | Subcutaneous | 5 IU, 3X/DAY (BEFORE MEALS), ON A SLIDING SCALE | 0 | 5 | IU | INJECTION | TID | ||||||
113830105 | 11383010 | 11 | C | LISINOPRIL HYDROCHLOROTHIAZIDE 10/12.5 | 2 | Oral | 1 PILL ([HYDROCHLOROTHIAZIDE 12.5 MG]/ [LISINOPRIL 10 MG]), DAILY | 0 | 1 | DF | |||||||||
113830105 | 11383010 | 12 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, ONE PILL DAILY AT BEDTIME | 0 | 5 | MG | ||||||||
113830105 | 11383010 | 13 | C | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
113830105 | 11383010 | 1 | Diabetic neuropathy |
113830105 | 11383010 | 5 | Diabetes mellitus |
113830105 | 11383010 | 6 | Heart rate decreased |
113830105 | 11383010 | 7 | Blood cholesterol abnormal |
113830105 | 11383010 | 8 | Diabetes mellitus |
113830105 | 11383010 | 10 | Diabetes mellitus |
113830105 | 11383010 | 11 | Blood pressure abnormal |
113830105 | 11383010 | 12 | Blood pressure abnormal |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
113830105 | 11383010 | Activities of daily living impaired | |
113830105 | 11383010 | Condition aggravated | |
113830105 | 11383010 | Diabetic neuropathy | |
113830105 | 11383010 | Drug ineffective | |
113830105 | 11383010 | Fatigue | |
113830105 | 11383010 | Insomnia | |
113830105 | 11383010 | Nausea | |
113830105 | 11383010 | Somnolence | |
113830105 | 11383010 | Thinking abnormal | |
113830105 | 11383010 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
113830105 | 11383010 | 1 | 20150703 | 20150801 | 0 | |
113830105 | 11383010 | 2 | 20150820 | 0 | ||
113830105 | 11383010 | 4 | 20160324 | 0 |